We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05026866
Brief Title: A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)
First Submitted : August 27, 2021
First Submitted that Met QC Criteria : August 27, 2021
First Posted : August 30, 2021
Last Update Submitted that Met QC Criteria : May 16, 2023
Last Update Posted : May 17, 2023